Detalhe da pesquisa
1.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Crit Care
; 27(1): 9, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627655
2.
Experiences and challenges with the new European Clinical Trials Regulation.
Trials
; 25(1): 3, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167484
3.
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei.
Pleura Peritoneum
; 8(1): 1-9, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020469